Skip to main content

Delix Therapeutics

Boston, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

$25.0M raised
Sep 2025
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Delix Therapeutics

How much funding has Delix Therapeutics raised?
Delix Therapeutics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Who are Delix Therapeutics's investors?
Delix Therapeutics's investors include RA Capital Management, Gaingels, Presight Capital, Artis Ventures, PsyMed Ventures.
Where is Delix Therapeutics headquartered?
Delix Therapeutics is headquartered in Boston, United States.
What does Delix Therapeutics do?
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
What stage is Delix Therapeutics at?
Delix Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Delix Therapeutics — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/delix-therapeutics. Accessed July 8, 2026.
APA
VCBacked. (2025). Delix Therapeutics — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/delix-therapeutics
Wikipedia (cite web)
{{cite web |title=Delix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/delix-therapeutics |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .